Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT after first episode of CDI
NCT03795233Phase 2Terminated
- Sponsor
- Boston Medical Center
- Start
- Aug 2019
- Primary completion
- Jan 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal microbiota transplant G3 capsules in Clostridium difficile infection (CDI), sponsored by Boston Medical Center. Started Aug 2019; status: terminated.
02
Drugs
Fecal microbiota transplant G3 capsules
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03795233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03795233.